Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Jun 30, 2022 | (FY)Jun 30, 2021 | (FY)Jun 30, 2020 | (FY)Jun 30, 2019 | (FY)Jun 30, 2018 | |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow (direct method) | ||||||||
| Cash income from operating activities | 88.65%3.19M | -45.41%1.69M | 27.54%3.1M | 109.53%2.43M | 45.94%1.16M | 179.72%793.82K | 283.8K | |
| Revenue from customers | --22.18K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Income from government grants | ---- | ---- | 0.00%15K | --15K | ---- | ---- | ---- | ---- |
| Other cash income from operating activities | 87.34%3.17M | -45.14%1.69M | 27.71%3.08M | 108.23%2.41M | 45.94%1.16M | 179.72%793.82K | --283.8K | ---- |
| Cash paid | 21.57%-6.18M | 23.35%-7.88M | -14.82%-10.28M | -35.99%-8.95M | -84.03%-6.58M | -6.07%-3.58M | -97.87%-3.37M | -1.7M |
| Payments to suppliers for goods and services | 21.57%-6.18M | 23.35%-7.88M | -14.82%-10.28M | -35.99%-8.95M | -84.03%-6.58M | -6.07%-3.58M | -97.87%-3.37M | ---1.7M |
| Direct interest paid | -2,009.64%-66.31K | 52.07%-3.14K | ---6.56K | ---- | 89.93%-785 | ---7.8K | ---- | ---- |
| Direct interest received | 156.93%134.33K | -77.11%52.28K | 811.77%228.38K | 23.93%25.05K | -57.18%20.21K | -67.62%47.2K | 178.01%145.75K | --52.43K |
| Operating cash flow | 52.40%-2.92M | 11.79%-6.14M | -7.10%-6.96M | -20.25%-6.5M | -96.98%-5.4M | 6.76%-2.74M | -78.14%-2.94M | ---1.65M |
| Investing cash flow | ||||||||
| Cash flow from continuing investing activities | -608.50%-582.96K | 16.99%-82.28K | -267.04%-99.12K | 60.44%-27.01K | -49.93%-68.27K | 58.70%-45.54K | 69.01%-110.26K | -355.76K |
| Net PPE purchase and sale | 71.79%-23.21K | 16.99%-82.28K | -267.04%-99.12K | 60.44%-27.01K | -49.93%-68.27K | 58.70%-45.54K | -924.64%-110.26K | ---10.76K |
| Net intangibles purchas and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---300K |
| Net business purchase and sale | ---519.75K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | ---40K | ---- | ---- | ---- | ---- | ---- | ---- | ---45K |
| Cash from discontinued investing activities | ||||||||
| Investing cash flow | -608.50%-582.96K | 16.99%-82.28K | -267.04%-99.12K | 60.44%-27.01K | -49.93%-68.27K | 58.70%-45.54K | 69.01%-110.26K | ---355.76K |
| Financing cash flow | ||||||||
| Cash flow from continuing financing activities | 49.46%4.19M | -22.74%2.8M | -69.35%3.63M | 100.73%11.85M | 4,249.23%5.9M | -142.22K | 8.29M | |
| Net issuance payments of debt | --1M | ---- | ---- | ---- | ---- | ---82.36K | ---- | ---- |
| Net common stock issuance | 13.23%3.28M | -22.03%2.9M | -68.65%3.72M | 99.43%11.85M | --5.94M | ---- | ---- | --8.29M |
| Net other financing activities | 52.02%-88.99K | -8.41%-185.45K | -1,017.22%-171.07K | 81.96%-15.31K | 29.11%-84.87K | ---119.72K | ---- | ---- |
| Cash from discontinued financing activities | ||||||||
| Financing cash flow | 49.46%4.19M | -22.74%2.8M | -69.35%3.63M | 100.73%11.85M | 4,249.23%5.9M | ---142.22K | ---- | --8.29M |
| Net cash flow | ||||||||
| Beginning cash position | -82.80%709.5K | -45.38%4.12M | 238.83%7.55M | 23.94%2.23M | -61.97%1.8M | -39.23%4.73M | 420.42%7.78M | --1.49M |
| Current changes in cash | 120.14%687.71K | 0.34%-3.41M | -164.38%-3.43M | 1,136.42%5.32M | 114.69%430.44K | 3.98%-2.93M | -148.56%-3.05M | --6.29M |
| End cash Position | 96.93%1.4M | -82.80%709.5K | -45.38%4.12M | 238.83%7.55M | 23.94%2.23M | -61.97%1.8M | -39.23%4.73M | --7.78M |
| Free cash from | 52.66%-2.94M | 11.86%-6.22M | -8.18%-7.06M | -19.24%-6.52M | -96.22%-5.47M | 8.64%-2.79M | -55.54%-3.05M | ---1.96M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |